Product Description
Product Name | Maitake Extract |
Latin Name | Grifola frondosa |
Color | Brown yellow fine powder |
Assay | 10%-50% Polysaccharides 10:1 |
Test method | UV / TLC |
Particle Size | 100% pass 80 mesh |
Heavy metals | ≤20ppm |
Loss on Drying | ≤5% |
Sulphated Ash | ≤5% |
Storage | In cool & dry place.Keep away from strong light and heat |
Shelf life | 2 years when properly stored |
Introduction | The fungus is native to China, the northeastern section of Japan, and North America, and it is valued as a therapeutic mushroom in traditional Chinese and Japanese herbology. In 2009, Memorial Sloan–Kettering Cancer Center completed a phase I/II human experiment that demonstrated Maitake could activate the immune systems of breast cancer patients. Maitake has been demonstrated in small studies with human cancer patients to boost immune system cells such as NK cells. Maitake has also been proven in vitro to boost immune system cells. In vivo studies revealed that Maitake could stimulate both the innate and adaptive immune systems. Maitake has been shown in vitro to induce apoptosis in numerous cancer cell lines as well as impede the development of certain cancer cells. Small investigations with human cancer patients demonstrated that the Maitake D-fraction, a component of the Maitake mushroom, has anti-cancer activity. In vitro studies revealed that the mushroom may have anti-metastatic capabilities. According to research, maitake has a hypoglycemic impact and may help with diabetes management. Maitake reduces blood sugar levels because it naturally includes an alpha glucosidase inhibitor. Maitake contains antioxidants and may inhibit the enzyme cyclooxygenase partly. |
Packing
Logistic